Nicotine et dérivés de nicotine

Nicergoline EP Impurity B is a metabolite of nicergoline, a drug product. It has been synthesized for use as an impurity standard for analytical and pharmacopoeia purposes. Nicergoline EP Impurity B is not found in nature and has been shown to be metabolically stable in vitro. It can be used as a reference substance for the determination of nicergoline concentrations in human plasma samples.

Stability Air Sensitive Applications β-Nornicotyrine (cas# 494-98-4) is a compound useful in organic synthesis. References Beckett, A., et al.: J. Pharm. Pharmacol., 24, 115 (1972), Zwickenpflug, W., et al.: Chem. Res. Toxicol., 19, 150 (2006),

CP-809101 hydrochloride is a potent and selective 5-HT2C receptor agonist (pEC50: 9.96/7.19/6.81 for human 5-HT2C/5-HT2B/5-HT2A receptors).

Applications Nudifloramide is a metabolite of Niacin (or Nicorinic acid). References Felsted, R., et al.: J. Biol. Chem., 242, 1274 (1967), Igel, M., et al.: Eur. J. Clin. Pharmacol., 57, 357 (2001), Kashyap, M., et al.: Am. J. Cardiol., 89, 672 (2002), Bottorff, M., et al.: Am. J. Cardiol., 97, 27 (2006),

Impurity Nicotine USP Related Compound F (3-(pyrrolidine-2-yl)pyridine) Stability Light Sensitive Applications (RS)-Nornicotine is a tobacco alkaloid and the major Nicotine (N412420) metabolite in brain. Nornicotine appears to activate different nAChR subtypes, has a better pharmacokinetic profile, and produces less toxicity than Nicotine. Nornicotine shows a significant analgesic activity. Nicotine USP Related Compound F (3-(pyrrolidine-2-yl)pyridine). References Hecht, S., et al.: Carcinogenesis, 9, 875 (1988), Rivenson, A., et al.: Cancer Res., 48, 6912 (1988), Hoffmann, D., et al.: Chem. Res. Toxicol., 14, 767 (2001), Kool, J., et al.: J. Med. Chem., 49, 3287 (2006), Kool, J., et al.: Drug Metab. Dispos., 35, 640 (2007),

Applications Labelled Nudifloramide (N925500). Nudifloramide is a metabolite of Niacin (or Nicorinic acid). References Felsted, R., et al.: J. Biol. Chem., 242, 1274 (1967), Igel, M., et al.: Eur. J. Clin. Pharmacol., 57, 357 (2001), Kashyap, M., et al.: Am. J. Cardiol., 89, 672 (2002), Bottorff, M., et al.: Am. J. Cardiol., 97, 27 (2006),

Applications The (S)-metabolite of Nicotine (N412420). Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Armstrong, D., et al.: Chirality, 11, 82 (1999), Carmella, S., et al.: Carcinogenesis, 21, 839 (2000),

Stability Hygroscopic, Light Sensitive Applications (R,S)-Anatabine is a metabolite of Nicotine (N412420). Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Quan, P.M., et al.: J. Org. Chem., 30, 2769 (1965), Maciuk, A., et al.: J. Pharm. Biomed. Anal., 48, 238 (2008),

Applications 2-Chloro-rac-Nicotine is a metabolite of rac-Nicotine (N412420); an active stimulant having both addictive and carcinogenic properties. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Lowry, T., et al.: J. Chem. Soc., 319 (1931);

Applications A nicotinic receptor agonist; brain rubidium efflux pharmacol. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Alkondon, M., et al.: J. Pharmacol. Exp. Ther., 271, 494 (1994), Wang, F., et al.: J. Biol. Chem., 271, 17656 (1996), Corringer, P., et al.: J. Neurosci., 18, 648 (1998),

Applications (±)-Cotinine-2,4,5,6-d4 (pyridine-d4) (CAS# 350818-68-7) is a useful isotopically labeled research compound.